Washington Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,500
| Closed | -$535K | – | 112 |
|
|
2024
Q2 | $535K | Hold |
6,500
| – | – | 0.45% | 69 |
|
|
2024
Q1 | $568K | Hold |
6,500
| – | – | 0.46% | 71 |
|
|
2023
Q4 | $627K | Hold |
6,500
| – | – | 0.54% | 53 |
|
|
2023
Q3 | $575K | Hold |
6,500
| – | – | 0.53% | 51 |
|
|
2023
Q2 | $563K | Hold |
6,500
| – | – | 0.48% | 61 |
|
|
2023
Q1 | $632K | Hold |
6,500
| – | – | 0.56% | 42 |
|
|
2022
Q4 | $673K | Sell |
6,500
-1,700
| -21% | -$176K | 0.62% | 42 |
|
|
2022
Q3 | $695K | Hold |
8,200
| – | – | 0.7% | 38 |
|
|
2022
Q2 | $680K | Hold |
8,200
| – | – | 0.65% | 40 |
|
|
2022
Q1 | $632K | Hold |
8,200
| – | – | 0.52% | 53 |
|
|
2021
Q4 | $724K | Hold |
8,200
| – | – | 0.59% | 47 |
|
|
2021
Q3 | $634K | Hold |
8,200
| – | – | 0.56% | 44 |
|
|
2021
Q2 | $684K | Hold |
8,200
| – | – | 0.83% | 38 |
|
|
2021
Q1 | $619K | Hold |
8,200
| – | – | 0.58% | 56 |
|
|
2020
Q4 | $719K | Hold |
8,200
| – | – | 0.69% | 39 |
|
|
2020
Q3 | $624K | Buy |
8,200
+1,700
| +26% | +$129K | 0.64% | 45 |
|
|
2020
Q2 | $802K | Hold |
6,500
| – | – | 0.89% | 28 |
|
|
2020
Q1 | $549K | Hold |
6,500
| – | – | 0.69% | 42 |
|
|
2019
Q4 | $550K | Buy |
6,500
+2,900
| +81% | +$245K | 0.47% | 52 |
|
|
2019
Q3 | $243K | Hold |
3,600
| – | – | 0.24% | 92 |
|
|
2019
Q2 | $308K | Buy |
+3,600
| New | +$308K | 0.35% | 85 |
|